Veru Provides FDA Update on Request for Emergency Use Authorization for Sabizabulin for Hospitalized COVID-19 Patients at High Risk for ARDS

Source: Nasdaq GlobeNewswire / 02 Mar 2023 15:01:00   America/Chicago